Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,570 Prostate Cancer
clinical trials

Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Ogden Regional Medical Center
mi
from
Ogden, UT
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Stanford Cancer Institute Palo Alto
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
University Hospitals Portage Medical Center
mi
from
Ravenna, OH
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Delbert Day Cancer Institute at PCRMC
mi
from
Rolla, MO
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Siteman Cancer Center at Saint Peters Hospital
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
UH Seidman Cancer Center at Salem Regional Medical Center
mi
from
Salem, OH
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Promedica Flower Hospital
mi
from
Sylvania, OH
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Cotton O'Neil Cancer Center / Stormont Vail Health
mi
from
Topeka, KS
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Gene Upshaw Memorial Tahoe Forest Cancer Center
mi
from
Truckee, CA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Wright-Patterson Medical Center
mi
from
Wright-Patterson Air Force Base, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Hampton, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Hartford, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Harvey, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Huntersville, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Lafayette, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Manchester, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Norwalk, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Paramus, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Post Falls, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Providence, RI
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Scarborough, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
South Miami, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Temple, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Westwood, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Albany, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Bethany, OK
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Bristol, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Easton, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Elyria, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
21st Century Oncology
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Houston Willowbrook Radiation Oncology
mi
from
Houston, TX
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Allegheny General Hospital, Allegheny Health Network
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Status: Enrolling, Phase I
Updated: 12/31/1969
University Health Network-Princess Margaret Hospital
mi
from
Toronto,
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Clinical Research Facility
mi
from
Greenbrae, CA
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Clinical Research Facility
mi
from
Wheeling, WV
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Oncology Clinical Trial
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Caba,
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 6/19/2014
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 6/19/2014
Clinical Research Facility
mi
from
Greenville, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 6/19/2014
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 6/19/2014
Clinical Research Facility
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 6/19/2014
Clinical Research Facility
mi
from
Oxnard, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 6/19/2014
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
A Study of TAS-120 in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Mary Crowley
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
AZD8186 First Time In Patient Ascending Dose Study
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
AZD8186 First Time In Patient Ascending Dose Study
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-52)
Status: Enrolling, Phase II
Updated: 5/17/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-52)
Status: Enrolling, Phase II
Updated: 5/17/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-52)
Status: Enrolling, Phase II
Updated: 5/17/2016
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling, Phase III
Updated: 9/23/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling, Phase III
Updated: 9/23/2015
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling, Phase III
Updated: 9/23/2015
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
McFarland Clinic PC - Ames
mi
from
Ames, IA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Duluth Clinic Ashland
mi
from
Ashland, WI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Central Care Cancer Center - Bolivar
mi
from
Bolivar, MO
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Brighton
mi
from
Brighton, MI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Alphonsus Cancer Care Center-Caldwell
mi
from
Caldwell, ID
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Hematology Oncology Consultants-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
UM Sylvester Comprehensive Cancer Center at Coral Springs
mi
from
Coral Springs, FL
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Essentia Health - Deer River Clinic
mi
from
Deer River, MN
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Main Line Health Center-Exton
mi
from
Exton, PA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Florida Health Science Center ?? Gainesville
mi
from
Gainesville, FL
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Northeast Georgia Medical Center-Gainesville
mi
from
Gainesville, GA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Yale-New Haven Shoreline Medical Center
mi
from
Guilford, CT
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Essentia Health Hibbing Clinic
mi
from
Hibbing, MN
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Hawaii Oncology Inc-POB I
mi
from
Honolulu, HI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Essentia Health - Jamestown Clinic
mi
from
Jamestown, ND
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Good Samaritan Medical Center
mi
from
Lafayette, CO
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Alliance for Childhood Diseases/Cure 4 the Kids Foundation
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Comprehensive Cancer Centers of Nevada - Town Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Michigan Breast Specialists-Macomb Township
mi
from
Macomb, MI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Macomb Medical Campus
mi
from
Macomb, MI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Fairview Maple Grove Medical Center
mi
from
Maple Grove, MN
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
UH Seidman Cancer Center at Southwest General Hospital
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Lake Norman Radiation Oncology Center-Mooresville
mi
from
Mooresville, NC
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Thompson Oncology Group-Oak Ridge
mi
from
Oak Ridge, TN
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Health Central
mi
from
Ocoee, FL
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Ascension Mercy Hospital
mi
from
Oshkosh, WI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Camden Clark Medical Center
mi
from
Parkersburg, WV
Click here to add this to my saved trials
1 … 56 57 58 59 60 61 62 63 64 65 66